| DRUG WATCH |
|
| Year : 2015 | Volume
: 47
| Issue : 3 | Page : 328-329 |
Neuroleptic malignant syndrome in cycloserine-induced psychosis
Neena S Sawant, Natasha S Kate, Swaroop S Bhatankar, Prathamesh S Kulkarni
Department of Psychiatry, Seth G.S.M.C and KEM Hospital, Mumbai, Maharashtra, India
Correspondence Address:
Dr. Neena S Sawant
Department of Psychiatry, Seth G.S.M.C and KEM Hospital, Mumbai, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.157134
A 33-year-old multidrug-resistant tuberculosis female patient diagnosed as cycloserine-induced psychosis developed several neuroleptic side effects such as extrapyramidal reaction, neuroleptic malignant syndrome, and drug-induced parkinsonism while she was being treated with initially haloperidol and then olanzapine over a period of 2 months . Patient's antipsychotic medications were withdrawn, and treatment with bromocriptine showed prompt recovery. The multiple neurological adverse effects which the patient developed had implications on the management of the complications as well as her illness.
[FULL TEXT] [PDF]*
|
